Indefinite Delivery Contract SPE2DU25D3107

The Indefinite Delivery Contract (IDC) SPE2DU25D3107 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,999,999 contract covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The IDC serves as a primary vehicle for DLA to efficiently procure essential medical commodities needed by military treatment facilities, veterans' healthcare programs, and other federal beneficiaries.

The IDC is part of the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition, which aims to establish multiple regional Prime Vendor Contracts to provide worldwide pharmaceutical support. The $30.3 billion procurement will make at least three separate regional awards, with the intent to diversify the government's supply base and increase resiliency during contingency operations. Amerisourcebergen's IDC is one of the regional contracts awarded under this overarching PPV-G GEN V program, which has a 30-month base period and three 30-month option periods, running through December 2036.